Home › NDC Lookup › Ingredients › Landiolol
📦 NDC / package directory — not a drug information page

Landiolol NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Landiolol products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

3
Package NDCs
4
Products
4
Active listings
0
Discontinued
3
Labelers
1
Strengths
2
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
LANDIOLOL HYDROCHLORIDE 280 mg/1 4
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 3
POWDER, FOR SOLUTION 1
Top labelers
AOP Orphan Pharmaceuticals GmbH 2
AOP Health US, LLC 1
LYOCONTRACT GmbH 1

Browse records — 4 products

Drug / product Billing NDC NADAC / unit Status
LANDIOLOL 280 mg/1 POWDER, FOR SOLUTION LYOCONTRACT · NDC 71956-0110-01 · 4 BOX in 1 CARTON (71956-110-01) / 25 VIAL, GLASS in 1 BOX / 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS 71956-0110-01 — On market View →
RAPIBLYK landiolol 280 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION AOP · NDC 84381-0110-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 84381-0110-01 — On market View →
RAPIBLYK landiolol 280 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION AOP · NDC 87073-0110-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (87073-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 87073-0110-01 — On market View →
RAPIBLYK landiolol 280 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION AOP · NDC 84381-0110-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 84381-0110-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.